Literature DB >> 27631520

Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Lien N Hoang1, Amandeep Aneja, Niamh Conlon, Deborah F Delair, Sumit Middha, Ryma Benayed, Martee L Hensley, Kay J Park, Travis J Hollmann, Meera R Hameed, Cristina R Antonescu, Robert A Soslow, Sarah Chiang.   

Abstract

Endometrial stromal sarcomas (ESS) are often underpinned by recurrent chromosomal translocations resulting in the fusion of genes involved in epigenetic regulation. To date, only YWHAE-NUTM2 rearrangements are associated with distinctive high-grade morphology and aggressive clinical behavior. We identified 3 ESS morphologically mimicking myxoid leiomyosarcoma of the uterus and sought to describe their unique histopathologic features and identify genetic alterations using next-generation sequencing. All cases displayed predominantly spindled cells associated with abundant myxoid stroma and brisk mitotic activity. Tumors involved the endometrium and demonstrated tongue-like myometrial infiltration. All 3 were associated with an aggressive clinical course, including multisite bony metastases in 1 patient, progressive peritoneal disease after chemotherapy in another, and metastases to the lung and skin in the last patient. All 3 ESS were found to harbor ZC3H7B-BCOR gene fusions by targeted sequencing and fluorescence in situ hybridization. On the basis of the review of these cases, we find that ESS with ZC3H7B-BCOR fusion constitutes a novel type of high-grade ESS and shares significant morphologic overlap with myxoid leiomyosarcoma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27631520      PMCID: PMC5630222          DOI: 10.1097/PAS.0000000000000721

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  82 in total

1.  Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.

Authors:  Vera Grossmann; Enrico Tiacci; Antony B Holmes; Alexander Kohlmann; Maria Paola Martelli; Wolfgang Kern; Ariele Spanhol-Rosseto; Hans-Ulrich Klein; Martin Dugas; Sonja Schindela; Vladimir Trifonov; Susanne Schnittger; Claudia Haferlach; Renato Bassan; Victoria A Wells; Orietta Spinelli; Joseph Chan; Roberta Rossi; Stefano Baldoni; Luca De Carolis; Katharina Goetze; Hubert Serve; Rudolf Peceny; Karl-Anton Kreuzer; Daniel Oruzio; Giorgina Specchia; Francesco Di Raimondo; Francesco Fabbiano; Marco Sborgia; Arcangelo Liso; Laurent Farinelli; Alessandro Rambaldi; Laura Pasqualucci; Raul Rabadan; Torsten Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2011-10-19       Impact factor: 22.113

2.  The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.

Authors:  Cheng-Han Lee; Adrian Mariño-Enriquez; Wenbin Ou; Meijun Zhu; Rola H Ali; Sarah Chiang; Frédéric Amant; C Blake Gilks; Matt van de Rijn; Esther Oliva; Maria Debiec-Rychter; Paola Dal Cin; Jonathan A Fletcher; Marisa R Nucci
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

3.  High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.

Authors:  Andrew P Sciallis; Patrick P Bedroske; John K Schoolmeester; William R Sukov; Gary L Keeney; Jennelle C Hodge; Debra A Bell
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

4.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Authors:  R Coleman Lindsley; Brenton G Mar; Emanuele Mazzola; Peter V Grauman; Sarah Shareef; Steven L Allen; Arnaud Pigneux; Meir Wetzler; Robert K Stuart; Harry P Erba; Lloyd E Damon; Bayard L Powell; Neal Lindeman; David P Steensma; Martha Wadleigh; Daniel J DeAngelo; Donna Neuberg; Richard M Stone; Benjamin L Ebert
Journal:  Blood       Date:  2014-12-30       Impact factor: 22.113

5.  Unusual morphologic features of endometrial stromal tumors: a report of 2 cases.

Authors:  Patricia M Baker; Holger Moch; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

6.  Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant.

Authors:  Sarah Cohen-Gogo; Cécile Cellier; Jean-Michel Coindre; Véronique Mosseri; Gaëlle Pierron; Cécile Guillemet; Antoine Italiano; Laurence Brugières; Daniel Orbach; Valérie Laurence; Olivier Delattre; Jean Michon
Journal:  Pediatr Blood Cancer       Date:  2014-08-31       Impact factor: 3.167

7.  Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.

Authors:  Daniel S Kapp; Jacob Y Shin; John K Chan
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

8.  Myxoid leiomyosarcoma of the uterus. A report of six cases.

Authors:  M E King; G R Dickersin; R E Scully
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

9.  BCOR regulates myeloid cell proliferation and differentiation.

Authors:  Q Cao; M D Gearhart; S Gery; S Shojaee; H Yang; H Sun; D-C Lin; J-W Bai; M Mead; Z Zhao; Q Chen; W-W Chien; S Alkan; T Alpermann; T Haferlach; M Müschen; V J Bardwell; H P Koeffler
Journal:  Leukemia       Date:  2016-02-05       Impact factor: 11.528

10.  Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma.

Authors:  Ioannis Panagopoulos; Francesca Micci; Jim Thorsen; Ludmila Gorunova; Anne Mette Eibak; Bodil Bjerkehagen; Ben Davidson; Sverre Heim
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

View more
  32 in total

1.  DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.

Authors:  Felix K F Kommoss; Damian Stichel; Daniel Schrimpf; Mark Kriegsmann; Basile Tessier-Cloutier; Aline Talhouk; Jessica N McAlpine; Kenneth T E Chang; Dominik Sturm; Stefan M Pfister; Laura Romero-Pérez; Thomas Kirchner; Thomas G P Grünewald; Rolf Buslei; Hans-Peter Sinn; Gunhild Mechtersheimer; Peter Schirmacher; Dietmar Schmidt; Hans-Anton Lehr; Felix Sahm; David G Huntsman; C Blake Gilks; Friedrich Kommoss; Andreas von Deimling; Christian Koelsche
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-25       Impact factor: 4.553

2.  BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.

Authors:  Sarah Chiang; Cheng-Han Lee; Colin J R Stewart; Esther Oliva; Lien N Hoang; Rola H Ali; Martee L Hensley; Javier A Arias-Stella; Denise Frosina; Achim A Jungbluth; Ryma Benayed; Marc Ladanyi; Meera Hameed; Lu Wang; Yu-Chien Kao; Cristina R Antonescu; Robert A Soslow
Journal:  Mod Pathol       Date:  2017-06-16       Impact factor: 7.842

3.  ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change.

Authors:  Ondrej Ondič; Barbora Bednářová; Nikola Ptáková; Veronika Hájková; Petr Šteiner; Henrieta Šidlová; Jiří Presl; Jiří Bouda; Reza Alaghehbandan; Michal Michal
Journal:  Virchows Arch       Date:  2020-01-14       Impact factor: 4.064

4.  BCOR-CCNB3 fusion and BCOR internal tandem duplication in undifferentiated round cell sarcoma: a pathologic and molecular study of 5 cases.

Authors:  Yang Yang; Huijuan Shi; Jiaxin Zheng; Huabin Gao; Tiantian Zhen; Fenfen Zhang; Anjia Han
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 5.  The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.

Authors:  Roman Groisberg; Jason Roszik; Anthony Conley; Shreyaskumar R Patel; Vivek Subbiah
Journal:  Curr Oncol Rep       Date:  2017-10-13       Impact factor: 5.075

Review 6.  [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].

Authors:  S F Lax
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

Review 7.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

8.  PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.

Authors:  Sarah Chiang; Wesley Samore; Lei Zhang; Yun-Shao Sung; Gulisa Turashvili; Rajmohan Murali; Robert A Soslow; Martee L Hensley; David Swanson; Brendan C Dickson; Colin J R Stewart; Esther Oliva; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

9.  Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors.

Authors:  Nikola Ptáková; Markéta Miesbauerová; Ján Kosťun; Petr Grossmann; Henrieta Šidlová; Jaroslav Pavelka; Jiří Presl; Reza Alaghehbandan; Jiří Bouda; Ondrej Ondič
Journal:  Virchows Arch       Date:  2018-08-16       Impact factor: 4.064

10.  ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.

Authors:  Natasha Lewis; Robert A Soslow; Deborah F Delair; Kay J Park; Rajmohan Murali; Travis J Hollmann; Ben Davidson; Francesca Micci; Ioannis Panagopoulos; Lien N Hoang; Javier A Arias-Stella; Esther Oliva; Robert H Young; Martee L Hensley; Mario M Leitao; Meera Hameed; Ryma Benayed; Marc Ladanyi; Denise Frosina; Achim A Jungbluth; Cristina R Antonescu; Sarah Chiang
Journal:  Mod Pathol       Date:  2017-12-01       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.